Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00383487 · ClinicalTrials.gov registry record · Phase 2
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
A Phase 2 study, sponsored by Stanford University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00383487: Clinical Trial Phase 2 study, sponsored by Stanford University.
NCT00383487 is a Phase 2 study that was terminated before completion, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00383487, a Phase 2 study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
To determine whether, in this patient population, treatment with calcitriol and Naproxen is more effective in delaying the growth of prostate cancer than treatment with calcitriol alone as seen in historical controls.
Interventions
- DRUG Calcitriol
- DRUG Naproxen-n-butyl nitrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-03 |
| Est. Completion | 2007-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00383487
The ClinicalTrials.gov registry entry for NCT00383487 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Calcitriol is the first listed.
NCT00383487 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00383487 about?
NCT00383487 is a clinical study titled "A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer". To determine whether, in this patient population, treatment with calcitriol and Naproxen is more effective in delaying the growth of prostate cancer than treatment with calcitriol alone as seen in historical controls.
What is the current status of trial NCT00383487?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2005-03. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00383487?
The interventions under investigation include: Calcitriol (DRUG), Naproxen-n-butyl nitrate (DRUG).
Who is sponsoring clinical trial NCT00383487?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.